CLINICAL EFFICACY OF CEFTRIAXONE VERSUS CIPROFLOXACIN IN PAEDIATRIC ENTERIC FEVER

Authors

  • Anila Farhat
  • Asma Shaukat
  • Tariq Mahmood Khan

DOI:

https://doi.org/10.51985/JBUMDC2018031

Keywords:

Clinical Efficacy, Ceftriaxone, Ciprofloxacin, Enteric Fever in Children, Defervescence

Abstract

Objective: Determination of the clinical effectiveness of ciprofloxacin versus ceftriaxone in children with enteric fever on the basis of defervescence within 72 hours of commencement of treatment. Duration and Place of Study: This randomized controlled trial study was carried out from 15th May to 15th November 2017 in pediatrics units of Benazir Bhutto Shaheed Teaching Hospital Abbottabad and Jinnah International Hospital Abbottabad. Methodology: 90 children with uncomplicated enteric fever were admitted and divided randomly into two groups, Group A was administered I/V Ceftriaxone 75mg/kg OD and Group B was given I/V Ciprofloxacin 10mg/kg BD for seven days. Response to drug was taken as defervescence within 72 hours while continued fever after 72 hours was taken as no response. The data was analyzed by using SPSS Version 21.00. Results: In our research study 53(58.9%) children were male and 37(41.1%) patients were female. The mean age was 8.43±3.17 years encompassing 4 to 14 years, mean weight of the patients in kg was 29.54±10.8 kg. Efficacy of ceftriaxone group was 93.3% while in ciprofloxacin group 62.2% patients became afebrile in 72 hours. The proportion of achieving defervescence within 72 hours was higher with ceftriaxone than with ciprofloxacin Conclusion: Ceftriaxone is more efficacious in terms of achieving defervescence than ciprofloxacin in children having enteric fever.

References

Background document: The diagnosis, treatment and

prevention of typhoid fever. Communicable Disease

Surveillance and Response Vaccines and Biologicals. World

Health Organization. Cited 2015. Available from:

http://www.who. int/rpc/TFGuideWHO.pdf

Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D,

Bhattacharya SK, Agtini MD et al. A study of typhoid fever

in five Asian countries: disease burden and implications for

controls. Bull World Health Organ. 2008; 86(4): 260-8.

Zhou K, Sauve LJ, Richardson SE, Ford-Jones EL, Morris

SK. Enteric Fever in a Multicultural Canadian Tertiary Care

Pediatric Setting: A 28-Year Review. J Pediatric Infect Dis

Soc. 2017; 6(1): 98–101

Azmatullah A, Qamar FN, Thaver D, Zaidi AKM, Bhutta ZA.

Systematic review of the global epidemiology, clinical and

laboratory profile of enteric fever. J Glob Health. 2015; 5(2):

doi: 10.7189/jogh.05.020407.

Steele AD, Burgess DCH, Diaz Z, Carey ME, Zaidi AKM.

Challenges and Opportunities for Typhoid Fever Control: A

Call for Coordinated Action. Clinical Infectious Diseases.

; 62(s1): S4–S8.

Britto C, Pollard AJ, Voysey M, Blohmke CJ. An Appraisal

of the Clinical Features of Pediatric Enteric Fever: Systematic

Review and Meta-analysis of the Age-Stratified Disease

Occurrence. Clinical Infectious Diseases. 2017; 64(11): 1604-

Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai

RL. Typhoid fever. Lancet. 2015; 385(9973): 1136-45

Mandal S, Mandal MD, Pal NK. Antibiotic resistance of

Salmonella enterica serovar Paratyphi A in India: Emerging

and reemerging problem. Journal of postgraduate medicine.

; 52(3): 163

Nair BT, Simalti AK, Sharma S. Study comparing ceftriaxone

with azithromycin for the treatment of uncomplicated typhoid

fever in children of India. Ann Trop Med Public Health 2017;

: 205-10

Naveed A, Ahmed Z. Treatment of Typhoid Fever in Children:

Comparison of Efficacy of Ciprofloxacin with Ceftriaxone.

European Scientific Journal. 2016; 12(6): 346-355. doi:

19044/esj.2016.v12n6p346

Khan MI, Soofi SB, Ochiai RL, Khan MJ, Sahito SM, Habib

MA, et al. Epidemiology, clinical presentation and patterns

of drug resistance of Salmonella Typhi in Karachi, Pakistan.

The Journal of Infection in Developing Countries. 2012;

(10): 704-14.

Crump JA, Luby SP, Mintz ED. The global burden of typhoid

fever. Bulletin of World Health Organization. 2004; 82(5):

-53

Parry CM. Treatment of multidrug-resistant and nalidixic

acid-resistant typhoid fever in VietNam. Transactions of the

Royal Society of Troical Medicine and Hygiene 2004; 98(7):

-422

Cooke FJ, Day M, Wain J, Ward LR, Threlfall EJ. Cases of

typhoid fever imported into England, Scotland and Wales.

Transactions of Royal Society of Tropical Medicine and

Hygiene. 2007; 101(4): 398-404

Karkey A, Arjyal A, Anders KL,et al. The burden and

characteristic of enteric fever at a healthcare facility in a

densely populated area of Khatmandu. Plos One. 2010; 5:

e13988.

Kelly DF, Thorson S, Maskey M, et al. The burden of vaccine

preventable invasive bacterial infections and pneumonia in

children admitted to hospital in urban Nepal. Int J Infect Dis.

; 15: e17-23

Saha AK, Hassan MK, Kundu LC, Saha SK, Begum P. Study

of the clinical profile and antibiotic response in typhoid fever

at faridpur medical college hospital. Faridpur Med.Coll.J.

; 12(1): 02-04

Shah G, Ghimire A, Shrestha S. Clinical profile of culture

proven enteric fever in children at university teaching hospital,

Nepal. Journal of Patan Academy of Health Sciences. 2014;

(2): 42-45

Butt T, Ahmad RN, Salman M and Kazmi SY. Changing

trends in drug resistance among typhoid salmonellae in

Rawalpindi, Pakistan. East Mediterr Health J. 2005; 11: 1038-

Limpitikul W, Singchungchai P. Costs and Effectiveness of

Ciprofloxacin and Ceftriaxone in Treatment of Typhoid Fever

in Children in Thailand. International Journal of Public Health

Research 2013; 1(3): 192-7

Thaver D, Zaidi AKM and Bhutta ZA. A comparison of

fluoroquinolones versus other antibiotics for treating enteric

fever: meta analyses. BMJ. 2009; 338: b1865. doi: https://doi.

org/10.1136/bmj.b1865

Jeeyani HN, Prajapati BS, Bloch A. Enteric fever in children

– Clinical profile, sensitivity patterns and response to

antimicrobials. GCSMC J Med Sci. 2015; 4(1): 40-43

Wallace MR, Yousif AA, Mahroos GA, et al. Ciprofloxacin

versus ceftriaxone in the treatment of multiresistant typhoid

fever. Eur J Clin Microbiol Infect Dis.1993; 12: 907-10

Smith MD, Duong NM, Hoa NT et al.Comparison of ofloxacin

and ceftriaxone for short course treatment of enteric

fever.Antimicrob Agents Chemother. 1994; 38(8): 1716-20

Ganesh R, Janakiraman L, Thiruvengadam V, Sathiyasekeren

M. Profile of typhoid fever in children from a tertiary care

hospital in Chennai – South India. Indian J Paediatrics. 2010;

: 1089-92

Downloads

Published

2018-06-04

How to Cite

Anila Farhat, Asma Shaukat, & Tariq Mahmood Khan. (2018). CLINICAL EFFICACY OF CEFTRIAXONE VERSUS CIPROFLOXACIN IN PAEDIATRIC ENTERIC FEVER. Journal of Bahria University Medical and Dental College, 8(2), 67–71. https://doi.org/10.51985/JBUMDC2018031

Issue

Section

Original Articles